申请人:G. D. Searle & Co.
公开号:US03931411A1
公开(公告)日:1976-01-06
The administration to mammals of prostaglandin PGA.sub.2, derivatives of PGA.sub.2, methyl ester of .omega.-homo PGE.sub.1 and compounds structurally related to prostaglandins, such as alkyl 11,15-dihydroxy-15-alkyl-9-oxoprost-13-ynates and 11-methyl-15-hydroxy-9-oxoprosta-5-cis-13-trans-dienoic acid results in a state of tranquilization as opposed to general depression.
给哺乳动物使用前列腺素PGA.sub.2、PGA.sub.2衍生物、.omega.-homo PGE.sub.1的甲酯以及结构类似于前列腺素的化合物,例如烷基11,15-双羟基-15-烷基-9-酮前列腺-13-炔酸酯和11-甲基-15-羟基-9-酮前列腺-5-顺-13-反-二烯酸,会导致一种镇静状态,而不是一般的抑制状态。